| Filed | Form | Description | |
|---|---|---|---|
| 2/23/26 | DEFA14A | DEFA14A | → |
| 2/2/26 | DEFM14A | DEFM14A | → |
| 1/26/26 | DEFA14A | DEFA14A | → |
| 1/21/26 | PREM14A | PREM14A | → |
| 12/19/25 | DEFA14A | DEFA14A | → |
| 4/24/25 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/4/26 | 4 | 4 | → |
| 1/22/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| 1/6/26 | 4 | 4 | → |
| ↓ | |||
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania.